Effectiveness of Homoeopathy in Allergic Rhinitis

Background

1. Isopathy - using diluted forms of the actual allergen (e.g., house dust mite, grass pollen)
2. Individualized homoeopathy (IHT) - classical case-taking with a single constitutional remedy
3. Non-individualized homoeopathy (NIHT) - standardized fixed formulas (e.g., Galphimia glauca, homoeopathic nasal sprays)

Key Clinical Evidence

1. Systematic Review Specific to Allergic Rhinitis (Banerjee et al., 2017 - PMID: 28437146)

• 11 RCTs were eligible; all but one were placebo-controlled
• 6 trials used isopathy - unsuitable for meta-analysis due to heterogeneity
• Galphimia glauca (3 trials) - pooled meta-analysis showed:
  • Nasal symptom relief at 2 weeks: RR = 1.48 (95% CI 1.24-1.77) favoring homoeopathy
  • Nasal symptom relief at 4 weeks: RR = 1.27 (95% CI 1.10-1.46)
  • Ocular symptom relief at 2 weeks: RR = 1.55 (95% CI 1.33-1.80)
  • Ocular symptom relief at 4 weeks: RR = 1.37 (95% CI 1.21-1.56)
• A homoeopathic nasal spray vs. conventional nasal spray produced equivalent improvements
• Major caveat: 8/11 trials rated "high risk of bias"; only one trial had reliable evidence, showing a small positive but non-significant effect
• Conclusion: Low or uncertain evidence quality warrants caution; Galphimia glauca and homoeopathic nasal spray may have small beneficial effects

2. ARIA Update - CAM Systematic Review (Passalacqua et al., 2006 - PMID: 16675332)

• Reviewed for the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines
• Noted "some positive results with homoeopathy in good-quality trials in rhinitis, but a number of negative studies were also found"
• Concluded: not possible to provide evidence-based recommendations for homoeopathy; further trials needed
• Meta-analyses provided no clear evidence; methodology of CAM trials was frequently inadequate

3. Non-Individualized Homoeopathy Meta-Analysis (Mathie et al., 2019 - PMID: 30699444)

• 17 RCTs representing 15 conditions eligible
• For seasonal AR (cromolyn sodium as comparator): pooled SMD = 0.08, p = 0.46 - consistent with NIHT not differing from cromolyn sodium (non-inferiority)
• 14/17 trials rated high risk of bias; results were inconclusive overall

4. Landmark RCT Series by David Reilly (Taylor et al., 2000)

• A series of four RCTs from Glasgow using homoeopathic dilutions of allergens (isopathy)
• Reported homoeopathic treatment of perennial AR more effective than placebo
• Results were statistically significant but effect sizes were modest
• Cited in the Textbook of Family Medicine (9th ed.) as positive evidence, though contested

Specific Remedies Studied

Mechanistic Hypotheses

• Water memory / structural changes in diluted solutions (Benveniste hypothesis - largely discredited)
• Nanoparticle effects from source material surviving serial dilution
• Non-specific immunomodulation via the therapeutic interaction and consultation process
• Placebo effect - the extended, empathic consultation (often 1 hour for first visit) itself has measurable therapeutic benefit

Position of Regulatory/Scientific Bodies

• WHO acknowledges homoeopathy as widely used but calls for more rigorous evidence
• ARIA guidelines (2006): Cannot recommend homoeopathy for AR due to insufficient evidence
• UK House of Commons Science Committee (2010): Concluded homoeopathy is no better than placebo
• AYUSH (India): Officially recognizes and promotes homoeopathy; included in the national healthcare system
• Australian NHMRC (2015): Found no good-quality evidence that homoeopathy is effective for any health condition

2026 Update: Ongoing Research

• Confirmed feasibility challenges: recruitment difficulties, individualized treatment complicating standardization, the therapeutic relationship (consultation process) itself influencing outcomes
• Highlighted that the rigorous RCT design in homoeopathy is difficult due to its inherently individualized, holistic nature
• Evidence for homoeopathy's efficacy in AR remains "still limited" as of 2026

Critical Appraisal Summary

Practical Clinical Perspective

• Conventional care has failed or reached a plateau
• No conventional treatments exist or are tolerated
• Side effects of antihistamines/steroids are not tolerated
• Patients are reluctant to accept conventional care

Bottom Line

• Galphimia glauca has the strongest evidence base (multiple RCTs, meta-analysis favorable)
• Isopathy (allergen dilutions) shows mixed results - Reilly's series was positive, others negative
• Individualized homoeopathy has weak RCT support but positive observational data
• Overall evidence quality is low due to methodological limitations
• Mainstream allergy guidelines do not recommend homoeopathy as first-line therapy
• Homoeopathy is generally considered safe with minimal adverse effects, making it an acceptable adjunct or alternative when patients refuse or cannot tolerate standard treatment

Note: Recent meta-analyses (PMID: 30699444; PMID: 28437146) confirm the evidence remains inconclusive. The HOMEOSAR feasibility trial (2026) represents the current state of ongoing research.

BHMS Internship Thesis - Topic Selection Guide (Respiratory Focus)

First: What Study Designs Are Feasible for a BHMS Intern?

Top Recommended Thesis Topics for You

TIER 1 - Most Doable & High Impact

• Study 30-50 OPD patients over 3-6 months
• Assess symptoms using the Total Nasal Symptom Score (TNSS) before and after treatment
• Record the most frequently indicated remedies (Allium cepa, Arsenicum alb, Natrum mur, Sabadilla, etc.)
• Why good: Well-defined outcome tools, easy patient recruitment, directly builds on evidence gaps identified in literature

• Fixed-remedy study (no individualization needed - simpler design)
• Galphimia glauca has the strongest evidence base in all of homoeopathy for AR
• Outcome: TNSS, rhinorrhea score, sneezing score
• Why good: Clean, reproducible design; easier to get ethics clearance

• Two-arm study (Group A: individualized remedy, Group B: Galphimia glauca)
• Why good: Comparative design is more publishable; answers a real clinical question

• Assess using Asthma Control Test (ACT) score or PEFR (Peak Expiratory Flow Rate)
• Record individualized remedies + potency + frequency
• Why good: Asthma has objective, measurable outcome tools (PEFR meter is cheap)

• Mother tincture study - very feasible
• Outcome: symptom diary, cough severity score
• Why good: Already being done by other interns (see BVVS Medical College list); good precedent

TIER 2 - Good but Slightly More Complex

• 10-20 well-documented cases with miasmatic analysis
• Why good: More classical homoeopathic approach; good for Organon/Materia Medica departments

• Assess frequency of infections before and after treatment
• Useful constitutional remedies: Tuberculinum, Calcarea carb, Pulsatilla, Baryta carb

• Analyze 30-50 case records from your OPD
• Find the most common rubrics and most frequently prescribed remedies
• Why good: Pure repertory-based study, no patient follow-up needed if using existing records

How to Choose - Quick Decision Framework

1. Do I have access to enough patients? (Need at least 20-30 for a clinical study)
   • Yes → Go for a clinical/observational study
   • No → Go for a case series or literature review
2. How much time do I have for follow-up?
   • 3+ months → Prospective study
   • Less time → Retrospective study or case series
3. Does my guide/supervisor specialize in a sub-department?
   • Match your topic to your guide's department (Practice of Medicine, Organon, Repertory, Materia Medica)

My Top Recommendation for You

"A Prospective Observational Study to Evaluate the Effectiveness of Individualized Homoeopathic Treatment in Patients of Allergic Rhinitis"

• Uses TNSS (Total Nasal Symptom Score) as the primary outcome tool
• Enrolls 30-50 patients from OPD over 3-6 months
• Records: symptom scores at baseline, 1 month, 3 months, 6 months
• Secondary outcomes: Quality of Life (RQLQ - Rhinoconjunctivitis Quality of Life Questionnaire), frequency of rescue medication use
• Ethical: no placebo, just standard homoeopathic care documented prospectively

Next Steps

• Full thesis outline (all chapters: Introduction, Review of Literature, Aims & Objectives, Methodology, Observations, Discussion, Conclusion)
• Writing the Review of Literature chapter
• Designing your proforma / case record form
• Statistical analysis plan (which tests to use)
• Full thesis document as a Word file (.docx)

What's Inside the Thesis

How to Use This

1. Replace all bracketed text like [Candidate Name], [Institution Name], [Guide Name] with your actual details
2. Replace the sample data in Chapter 4 (Tables 4.1-4.8) with your actual collected patient data
3. Submit the proforma (Annexure I) to your guide for approval before starting data collection
4. Get IEC clearance before enrolling patients